Literature DB >> 20090674

Dosing in children.

N Holford1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20090674     DOI： 10.1038/clpt.2009.262

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  20 in total

1.  Why standards are useful for predicting doses.

Authors:  Nick H G Holford; Brian J Anderson
Journal:  Br J Clin Pharmacol       Date:  2017-02-02       Impact factor: 4.335

2.  Population pharmacokinetic analysis of fexofenadine in Japanese pediatric patients.

Authors:  Jean-Marie Martinez; Sonia Khier; Shigemichi Morita; Clémence Rauch; David Fabre
Journal:  J Pharmacokinet Pharmacodyn       Date:  2014-03-16       Impact factor: 2.745

Review 3.  Practical considerations for dose selection in pediatric patients to ensure target exposure requirements.

Authors:  April M Barbour; Michael J Fossler; Jeffrey Barrett
Journal:  AAPS J       Date:  2014-05-20       Impact factor: 4.009

Review 4.  Innovative clinical trial design for pediatric therapeutics.

Authors:  Matthew M Laughon; Daniel K Benjamin; Edmund V Capparelli; Gregory L Kearns; Katherine Berezny; Ian M Paul; Kelly Wade; Jeff Barrett; Phillip Brian Smith; Michael Cohen-Wolkowiez
Journal:  Expert Rev Clin Pharmacol       Date:  2011-09       Impact factor: 5.045

5.  Predicting pediatric age-matched weight and body mass index.

Authors:  Sherwin K B Sy; Eduardo Asin-Prieto; Hartmut Derendorf; Emil Samara
Journal:  AAPS J       Date:  2014-08-26       Impact factor: 4.009

6.  Randomized, open-label, multicentre pharmacokinetic studies of two dose levels of pantoprazole granules in infants and children aged 1 month through <6 years with gastro-oesophageal reflux disease.

Authors:  Brinda K Tammara; Janice E Sullivan; Kim G Adcock; Jaroslaw Kierkus; John Giblin; Natalie Rath; Xu Meng; Mary K Maguire; Gail M Comer; Robert M Ward
Journal:  Clin Pharmacokinet       Date:  2011-08       Impact factor: 6.447

Review 7.  Paediatric models in motion: requirements for model-based decision support at the bedside.

Authors:  Jeffrey S Barrett
Journal:  Br J Clin Pharmacol       Date:  2015-01       Impact factor: 4.335

Review 8.  A report from the pediatric formulations task force: perspectives on the state of child-friendly oral dosage forms.

Authors:  Anne Zajicek; Michael J Fossler; Jeffrey S Barrett; Jeffrey H Worthington; Robert Ternik; Georgia Charkoftaki; Susan Lum; Jörg Breitkreutz; Mike Baltezor; Panos Macheras; Mansoor Khan; Shreeram Agharkar; David Douglas MacLaren
Journal:  AAPS J       Date:  2013-08-02       Impact factor: 4.009

9.  Pharmacodynamic analysis of stress erythropoiesis: change in erythropoietin receptor pool size following double phlebotomies in sheep.

Authors:  Mohammad I Saleh; John A Widness; Peter Veng-Pedersen
Journal:  Biopharm Drug Dispos       Date:  2011-01-10       Impact factor: 1.627

10.  A multicenter, randomized, open-label, pharmacokinetics and safety study of pantoprazole tablets in children and adolescents aged 6 through 16 years with gastroesophageal reflux disease.

Authors:  Robert M Ward; Gregory L Kearns; Brinda Tammara; Phyllis Bishop; Molly A O'Gorman; Laura P James; Mitchell H Katz; Mary K Maguire; Natalie Rath; Xu Meng; Gail M Comer
Journal:  J Clin Pharmacol       Date:  2010-09-17       Impact factor: 3.126
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.